Francesco Marchesi

47PUBLICATIONS
318CO-AUTHORS
Immunogenetics (incl. genetic immunology)Medical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Decision makingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jul 25, 2026
Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study.

|Mar 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie

|Dec 24, 2025
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.

Jon Salmanton-García, Francesco Marchesi, Milan Navrátil

|Aug 21, 2025
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.

Roberto Cairoli, Lorenzo Del Castello, Silvia Imbergamo

|Aug 04, 2025
Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Simone Cesaro, Per Ljungman, Malgorzata Mikulska

|Jul 21, 2025
A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis.

Giulia Regazzo, Giulia Vari, Francesco Marchesi

Pageof 8

Frequent Collaborators

25 joint publications

Livio Pagano

16 joint publications

Jon Salmanton-García

15 joint publications

Oliver A Cornely

13 joint publications

Alberto López-García